Auteurs Sormani L, Montaudie H, Blot L, Heim M, Cardot Leccia N, Mhaidly R, Verhoeyen E, Regazzetti C, Nottet N, Cheli Y, De Donatis GM, Dabert Gay AS, Debayle D, Taquin Martin H, Gesbert F, Rocchi S, Tulic MK, Passeron T
The Journal of investigative dermatology Dec 2021
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma.Auteurs Berestjuk I, Lecacheur M, Carminati A, Diazzi S, Rovera C, Prod'homme V, Ohanna M, Popovic A, Mallavialle A, Larbret F, Pisano S, Audebert S, Passeron T, Gaggioli C, Girard CA, Deckert M, Tartare-Deckert S
EMBO molecular medicine Déc 2021
Meeting report of the 4th biennial Metabolism and Cancer symposium.Auteurs Abdel Hadi N, Boet E, Lahalle A, Lauture L, Refeyton A, Reyes-Castellanos G, Caplet N, Carrier A, Le Cam L, Mazure NM, Ricci JE, Rocchi S, Sarry JE, Vasseur S, Vlaski-Lafarge M, Rossignol R, Bost F
The FEBS journal Nov 2021
The Role of mRNA Translational Control in Tumor Immune Escape and Immunotherapy Resistance.Auteurs Cerezo M, Robert C, Liu L, Shen S
Cancer research Sep 2021
CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3.Auteurs Montaudié H, Sormani L, Dadone-Montaudié B, Heim M, Cardot-Leccia N, Tulic MK, Beranger G, Gay AS, Debayle D, Cheli Y, Raymond JH, Sohier P, Petit V, Rocchi S, Gesbert F, Larue L, Passeron T
The Journal of investigative dermatology Jul 2021
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?Auteurs Martel A, Lassalle S, Picard-Gauci A, Gastaud L, Montaudie H, Bertolotto C, Nahon-Esteve S, Poissonnet G, Hofman P, Baillif S
Cancers Jul 2021
Increased Activation of Innate Immunity and Pro-Apoptotic CXCR3B in Normal-Appearing Skin on the Lesional Site of Patients with Segmental Vitiligo.Auteurs Passeron T, Malmqvst VEA, Bzioueche H, Marchetti S, Rocchi S, Tulic MK
The Journal of investigative dermatology Juil 2021
Biguanides drugs: Past success stories and promising future for drug discovery.Auteurs Grytsai O, Myrgorodska I, Rocchi S, Ronco C, Benhida R
European journal of medicinal chemistry Juil 2021
Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma.Auteurs Zerhouni M, Martin AR, Furstoss N, Gutierrez VS, Jaune E, Tekaya N, Beranger GE, Abbe P, Regazzetti C, Amdouni H, Driowya M, Dubreuil P, Luciano F, Jacquel A, Tulic MK, Cluzeau T, O'Hara BP, Ben-Sahra I, Passeron T, Benhida R, Robert G, Auberger P, Rocchi S
Cancer research Juin 2021
Development and evaluation of fused benzazole analogs of anti-melanoma agent HA15.Auteurs Millet A, Filho MS, Hamouda-Tekaya N, Cavazza E, Abbe P, Rüdiger J, Plaisant M, Mayen J, Rocchi S, Ronco C, Benhida R
Future medicinal chemistry Juin 2021